Login / Signup
Margo Zaval
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Subarachnoid Hemorrhage
Men Who Have Sex With Men
Positive Breast Cancer
Glycemic Control
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Devra J Olson
,
Janelle Taylor
,
Kelsi Willis
,
Kelly M Hensley
,
Sean Allred
,
Margo Zaval
,
Lauren Farr
,
Robert Thurman
,
Nishi Jain
,
Renee F C Hein
,
Michelle Ulrich
,
Scott Peterson
,
Anita Kulukian
HER2-selective and reversible tyrosine kinase inhibitor tucatinib potentiates the activity of T-DM1 in preclinical models of HER2-positive breast cancer.
Cancer research communications
(2023)